WC
TMO icon

Westerkirk Capital’s Thermo Fisher Scientific TMO Stock Holding History

Westerkirk Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.52M Hold
17,000
– – 0.82% 27
2026
Q1 		$8.36M Hold
17,000
– – 0.9% 24
2025
Q4 		$9.85M Hold
17,000
– – 0.96% 22
2025
Q3 		$8.25M Hold
17,000
– – 0.94% 19
2025
Q2 		$6.89M Buy
+17,000
New +$7.11M 0.85% 23

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Westerkirk Capital's TMO Position: Q2 2026 in Review

Westerkirk Capital held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 17,000 shares worth $8.52M. The position accounts for 0.82% of the portfolio, ranked #27.

Westerkirk Capital first reported a position in TMO in Q2 2025 and has held it in 5 quarters since. The position peaked at $9.85M in Q4 2025. 2,624 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Westerkirk Capital held 17,000 shares of Thermo Fisher Scientific worth $8.52M as of Q2 2026.
  • Westerkirk Capital left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.82% of Westerkirk Capital's portfolio in Q2 2026, its #27 holding.
  • Westerkirk Capital first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 5 quarters since.
  • Westerkirk Capital's Thermo Fisher Scientific position peaked at $9.85M in Q4 2025.
  • 2,624 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Westerkirk Capital's 13F filing for Q2 2026, filed 10 Aug 2026.